Paper Details

  1. Home
  2. Paper Details

A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.

Author: CampoAntoinette, CaulkinsCarrie A, CoxSue Ellen, DavisPaula G, FagienSteven, GallagherConor J, YoelinSteven G

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

A retrospective chart review of 585 patients with hypotrichosis found that treatment with bimatoprost 0.03% for at least 12 months was safe and associated with high patient satisfaction. No instances of iris hyperpigmentation occurred.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The efficacy and safety of bimatoprost ophthalmic solution 0.03% for treating hypotrichosis were shown in a randomized controlled trial and in an open-label study. To date, no data on real-world experience have been published. OBJECTIVE: To evaluate long-term patient satisfaction, usage...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/01.DSS.0000452658.83001.d9

データ提供：米国国立医学図書館（NLM）

Bimatoprost: A New Oasis in the Desert of Eyelash Hypotrichosis

[Hypotrichosis] is a condition characterized by thin or sparse eyelashes, impacting a person's appearance and confidence. This study examines the long-term efficacy and safety of bimatoprost ophthalmic solution 0.03% for treating hypotrichosis. The researchers conducted a retrospective chart review and observational study to evaluate patient satisfaction, usage patterns, and adverse events over an extended period.

Navigating the Desert of Eyelash Growth

This study suggests that bimatoprost ophthalmic solution 0.03% is a safe and effective treatment for hypotrichosis, with a high level of patient satisfaction. The study also provides valuable insights into the long-term usage patterns of the medication.

Finding Beauty in the Desert

This research highlights the importance of personalized medicine approaches to addressing aesthetic concerns like hypotrichosis. The study's findings offer hope for individuals seeking a safe and effective treatment option to enhance their eyelashes and boost their confidence.

Dr.Camel's Conclusion

This study provides reassuring evidence of the safety and effectiveness of bimatoprost ophthalmic solution 0.03% in treating hypotrichosis. It offers a glimmer of hope for individuals seeking to improve their appearance and enhance their self-esteem.

Date :
  1. Date Completed 2014-11-14
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

25229783

DOI: Digital Object Identifier

10.1097/01.DSS.0000452658.83001.d9

Related Literature

Article Analysis
・Effects of bimatoprost ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.